Injection
Semaglutide + B12
A weekly GLP-1 injection that quiets cravings and supports steady, sustainable weight loss, paired with vitamin B12 for energy.
Starting at $99/mo

Lose the weight you carry and keep the years it costs you. Physician-led plans that look at what weight does to your heart, your sleep and your energy, not just the scale.
Age, hormones, and stress can change how your body manages weight.¹ The good news is there’s a specific mechanism behind this shift, and it’s the same one our plans are built to address.²
Our in-house care team of U.S.-licensed physicians and nurse practitioners finds the right plan and pace for your body, then adjusts as you progress so you’re never left guessing what to do next.
fewer major cardiovascular events (heart attack, stroke or cardiovascular death) with weekly semaglutide 2.4 mg in 17,604 adults with overweight and heart disease, over about 3 years.
SELECT trial, NEJM 2023fewer breathing interruptions per hour of sleep after one year of weekly tirzepatide in adults with obesity and sleep apnea, versus about 5 fewer on placebo (the two SURMOUNT-OSA trials).
SURMOUNT-OSA, NEJM 2024lower risk of developing type 2 diabetes with about 7% weight loss and regular activity in adults with prediabetes, over 3 years.
Diabetes Prevention Program, NEJM 2002Across 900,000 adults, moderate obesity shortened life by up to 4 years and severe obesity by up to 10, comparable to lifelong smoking. Prospective Studies Collaboration, The Lancet 2009
Trial results are with brand-name medicines at their studied doses, alongside diet and activity. Compounded medicines were not studied in these trials. They are averages, not a prediction of your result.
When the scale stalls, you’re not left to start over on your own. Our fully in-house care team stays with you throughout your journey, adjusting your treatment, dose, and pace as your body responds.
We’re here to celebrate your progress, guide you through setbacks, and protect what you worked for, with plans starting at $79 a month.
Start hereWeight loss is the visible part. It’s not the whole story. GLP-1 receptors exist throughout the body, and a growing body of research points to real metabolic and anti-inflammatory effects beyond the scale.
Real products and real prices from our pharmacy. Your physician helps you choose the medicine, the form and the dose.
Measured doses you give yourself at home, usually once a week or once a day.
Injection
A weekly GLP-1 injection that quiets cravings and supports steady, sustainable weight loss, paired with vitamin B12 for energy.
Starting at $99/mo
Injection
A weekly GLP-1 injection that quiets cravings and supports steady, sustainable weight loss, paired with glycine for better tolerance.
Starting at $99/mo
Injection
A weekly dual-action GLP-1/GIP injection for meaningful weight loss and appetite control, paired with vitamin B12 for energy.
Starting at $198/mo
Injection
A weekly dual-action GLP-1/GIP injection for meaningful weight loss and appetite control, paired with glycine for better tolerance.
Starting at $198/mo
Dissolves under the tongue. No needles.
Dissolving tablet
Semaglutide oral dissolving tablet for weight loss. GLP-1 receptor agonist in sublingual form. Escalating dose titration.
Starting at $219/mo
Dissolving tablet
Tirzepatide oral dissolving tablet. Dual GIP/GLP-1 agonist for weight loss. Escalating dose titration protocol.
Starting at $289/mo
Taken by mouth with water.
Tablet
Metformin commercial tablet for weight loss support and glucose metabolism. Take daily, 30-day supply.
30 tablets per month
Starting at $79/mo
Tablet
Topiramate commercial tablet for weight loss support and mood. Off-label for appetite reduction. Daily dose.
30 tablets per month
Starting at $79/mo
Tablet
Phentermine commercial tablet, a controlled stimulant for short-term weight loss. Requires video visit and monitoring.
30 tablets per month
Starting at $109/mo
Tablet
Ondansetron commercial tablet for nausea support during GLP-1 weight loss therapy. Take as needed.
30 tablets per month
Starting at $49/mo
Taken by mouth with water.
Capsule
Low-dose naltrexone for weight loss, appetite control, and inflammation support. Off-label use. Daily capsule.
30 capsules per month
Starting at $79/mo
Capsule
Combination of phentermine (stimulant) and topiramate (anticonvulsant) for weight loss. Controlled schedule III/V. Requires video visit.
30 capsules per month
Starting at $129/mo
12 treatments in this area, all from our live catalog.
Contact your provider immediately if you have severe stomach pain that does not go away (possible pancreatitis); a lump or swelling in your neck, hoarseness, or trouble swallowing (possible thyroid tumor); severe vomiting or diarrhea with signs of dehydration; symptoms of low blood sugar; or signs of a serious allergic reaction. Regular check-ins help your physician follow your response to treatment.
Nausea; diarrhea; vomiting; constipation; stomach pain; indigestion; injection-site reactions; tiredness; burping; hair loss; heartburn.
Adjust the scale to see the average one-year loss in the trials.
Your current weight (lbs):
270
In one year the average was (lbs):
41
Uses the roughly 15% mean weight loss over about a year in the brand-name trials (STEP 1, semaglutide 2.4 mg: 14.9% at 68 weeks; SURMOUNT-1, tirzepatide 15 mg: 20.9% at 72 weeks), with diet and exercise. A study average, not a prediction of your result; compounded versions were not studied in these trials. Adult figure: CDC, NHANES 2017–2018.
Weekly injection or daily dissolving tablet
Weekly injection or daily dissolving tablet
Both are prescribed and followed by a licensed physician, and you can switch as your needs change.
Compounded medications are not FDA-approved for safety, efficacy, or quality.

01
Answer a few health questions online. No appointment needed, no waiting rooms.

02
A U.S.-licensed physician reviews your information and decides whether a GLP-1 is right for you.

03
If prescribed, your medication ships to your door in discreet packaging.
Weight loss treatment prescribed and followed by a physician: here, GLP-1 medicines such as tirzepatide and semaglutide, alongside diet and activity. A U.S.-licensed physician reviews your health, prescribes only if it fits and adjusts the dose with you.
Both contain tirzepatide, but they are different products. Zepbound® is FDA-approved and made by Eli Lilly; compounded tirzepatide is prepared by a licensed U.S. pharmacy under your prescription and is not FDA-approved. We don't offer Zepbound. Zepbound® is a trademark of Eli Lilly and Company, not affiliated with Zepym Health.
Generally adults with a BMI of 30 or more, or 27 or more with a weight-related condition. A physician reviews your history before anything is prescribed. GLP-1s are not for people with a personal or family history of medullary thyroid cancer or MEN 2, or during pregnancy.
Semaglutide acts on GLP-1; tirzepatide acts on GLP-1 and GIP and produced more weight loss in its trials. Your physician helps you choose based on your goals, your history and how you tolerate the medicine.
Both come as a weekly injection under the skin or as a tablet that dissolves under the tongue once a day. The tablet avoids needles; your physician explains how each one is taken.
Tell your physician which medicine and dose you took and when. They decide the safest starting point for you.
Nausea, diarrhea, vomiting and constipation are the most common, mostly in the first weeks and when the dose goes up. Severe stomach pain needs medical attention right away.
Appetite usually quiets within the first weeks. Weight loss builds month by month as the dose steps up; in the trials it continued for more than a year. Results vary.
Yes. GLP-1 medicines are prescribed to adult men and women who meet the criteria.
Monthly, every 3 months or every 6 months; longer plans cost less per month. Shipping is free and you can pause or cancel anytime.
| 1 | Once-weekly semaglutide 2.4 mg in adults with overweight or obesity: mean weight change −14.9% vs −2.4% with placebo at 68 weeks.STEP 1. Wilding JPH et al. N Engl J Med, 2021. | STEP 1. Wilding JPH et al. N Engl J Med, 2021. |
| 2 | Tirzepatide once weekly for the treatment of obesity: mean weight change −20.9% with 15 mg at 72 weeks.SURMOUNT-1. Jastreboff AM et al. N Engl J Med, 2022. | SURMOUNT-1. Jastreboff AM et al. N Engl J Med, 2022. |
| 3 | 73.6% of U.S. adults aged 20 and over have overweight or obesity.CDC, NCHS. NHANES 2017–2018. | CDC, NCHS. NHANES 2017–2018. |
Compounded medications are not FDA-approved for safety, efficacy, or quality.